NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CAO Jeffrey J. Scherman sold 1,368 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $10,027.44. Following the completion of the sale, the chief accounting officer now owns 5,942 shares of the company’s stock, valued at $43,554.86. The trade was a 18.71 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
NeueHealth Stock Up 0.7 %
NeueHealth stock opened at $7.45 on Friday. The firm has a fifty day simple moving average of $5.56 and a two-hundred day simple moving average of $5.40. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $16.59. The company has a market capitalization of $61.72 million, a PE ratio of -0.15 and a beta of 0.57.
Institutional Investors Weigh In On NeueHealth
A number of hedge funds and other institutional investors have recently modified their holdings of NEUE. NEA Management Company LLC bought a new position in NeueHealth during the 2nd quarter worth approximately $14,834,000. Deer Management Co. LLC purchased a new stake in shares of NeueHealth during the second quarter valued at approximately $5,436,000. Partners Group Holding AG purchased a new stake in shares of NeueHealth during the third quarter valued at approximately $463,000. Finally, Renaissance Technologies LLC bought a new position in shares of NeueHealth in the second quarter worth approximately $312,000. Institutional investors own 63.88% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Stories
- Five stocks we like better than NeueHealth
- Short Selling – The Pros and Cons
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Using the MarketBeat Dividend Yield Calculator
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.